SHEILA BEHUNIN: Open Payments
NPI 1205417250 · EAST ELLIJAY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 39 payments from 15 companies in 2025. Trend: 2023 $292 · 2024 $508 · 2025 $1,117
Food & beverage: $1,017Education: $100
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $177 |
| AstraZeneca Pharmaceuticals LP | 3 | $151 |
| ABBVIE INC. | 12 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| Novo Nordisk Inc | 1 | $122 |
| Astellas Pharma US Inc | 2 | $119 |
| GlaxoSmithKline, LLC. | 1 | $91 |
| Boston Scientific Corporation | 2 | $53 |
| Lundbeck LLC | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: Korlym, VRAYLAR, CAPLYTA, Ozempic, AREXVY, WaveWriter Alpha Prime 16, REXULTI, INSPIRE.
Industry payments across GA — which companies pay providers there.
